Rare occurrence of type 2 diabetes mellitus in patients with sickle cell anaemia: assessing the contribution of inflammation, insulin resistance and glucose buffering capacity of abnormal haemoglobin

This review was designed to discuss the rare occurrence of diabetes mellitus (DM) in patients with sickle cell anaemia (SCA) with a particular focus on factors, such as life expectancy, body weight, chronic inflammation, insulin resistance, glucose buffering property of haemoglobin, and microRNAs (...

Full description

Bibliographic Details
Main Authors: Sheu Kadiri Rahamon, Sunday Peter Ogundeji, Samson Eshihokhale Olerimi, Kehinde Sola Akinlade
Format: Article
Language:English
Published: Poznan University of Medical Sciences 2022-03-01
Series:Journal of Medical Science
Subjects:
Online Access:https://jms.ump.edu.pl/index.php/JMS/article/view/604
_version_ 1811290409850109952
author Sheu Kadiri Rahamon
Sunday Peter Ogundeji
Samson Eshihokhale Olerimi
Kehinde Sola Akinlade
author_facet Sheu Kadiri Rahamon
Sunday Peter Ogundeji
Samson Eshihokhale Olerimi
Kehinde Sola Akinlade
author_sort Sheu Kadiri Rahamon
collection DOAJ
description This review was designed to discuss the rare occurrence of diabetes mellitus (DM) in patients with sickle cell anaemia (SCA) with a particular focus on factors, such as life expectancy, body weight, chronic inflammation, insulin resistance, glucose buffering property of haemoglobin, and microRNAs (miRNAs), aiming to stimulate research which will fill the existing knowledge gaps regarding the interplay between SCA and DM. Additionally, possible pharmacotherapeutic approaches to DM were also highlighted in the review. Google Scholar and PubMed search engines were used to search for the relevant keywords, such as sickle cell trait, sickle cell disease, sickle cell anaemia, insulin resistance, and diabetes mellitus. SCA patients appear to have β-cell dysfunction with a reduced insulin secretion, but present a similar insulin sensitivity status as other patients without haemoglobinopathy. Glucose buffering property of haemoglobin and the possible DM-protective roles of miRNAs in the sickled erythrocytes constitute some of the potential factors protecting SCA patients from developing DM. Sickle cell anaemia is associated with several complications and endocrinopathies, nevertheless, its coexistence with DM continues to be a rare observation. Proper elucidation of the mechanisms which seemingly confer ‘protection’ against DM in patients with SCA may provide some therapeutic insights regarding DM.
first_indexed 2024-04-13T04:12:24Z
format Article
id doaj.art-8549d66876804f1c9294442c01915c45
institution Directory Open Access Journal
issn 2353-9798
2353-9801
language English
last_indexed 2024-04-13T04:12:24Z
publishDate 2022-03-01
publisher Poznan University of Medical Sciences
record_format Article
series Journal of Medical Science
spelling doaj.art-8549d66876804f1c9294442c01915c452022-12-22T03:03:05ZengPoznan University of Medical SciencesJournal of Medical Science2353-97982353-98012022-03-0191110.20883/medical.e604Rare occurrence of type 2 diabetes mellitus in patients with sickle cell anaemia: assessing the contribution of inflammation, insulin resistance and glucose buffering capacity of abnormal haemoglobinSheu Kadiri Rahamon0Sunday Peter Ogundeji1Samson Eshihokhale Olerimi2Kehinde Sola Akinlade3Department of Immunology, College of Medicine, University of Ibadan, NigeriaDepartment of Haematology, University College Hospital, Ibadan and College of Medicine, University of Ibadan, NigeriaDepartment of Biochemistry, Edo University, Iyamho, NigeriaMetabolic Research Unit, Department of Chemical Pathology, University College Hospital, Ibadan and College of Medicine, University of Ibadan, Nigeria This review was designed to discuss the rare occurrence of diabetes mellitus (DM) in patients with sickle cell anaemia (SCA) with a particular focus on factors, such as life expectancy, body weight, chronic inflammation, insulin resistance, glucose buffering property of haemoglobin, and microRNAs (miRNAs), aiming to stimulate research which will fill the existing knowledge gaps regarding the interplay between SCA and DM. Additionally, possible pharmacotherapeutic approaches to DM were also highlighted in the review. Google Scholar and PubMed search engines were used to search for the relevant keywords, such as sickle cell trait, sickle cell disease, sickle cell anaemia, insulin resistance, and diabetes mellitus. SCA patients appear to have β-cell dysfunction with a reduced insulin secretion, but present a similar insulin sensitivity status as other patients without haemoglobinopathy. Glucose buffering property of haemoglobin and the possible DM-protective roles of miRNAs in the sickled erythrocytes constitute some of the potential factors protecting SCA patients from developing DM. Sickle cell anaemia is associated with several complications and endocrinopathies, nevertheless, its coexistence with DM continues to be a rare observation. Proper elucidation of the mechanisms which seemingly confer ‘protection’ against DM in patients with SCA may provide some therapeutic insights regarding DM. https://jms.ump.edu.pl/index.php/JMS/article/view/604EndocrinopathyHaemoglobinopathyPharmacotherapySickle cell anaemiaType 2 diabetes mellitusMicroRNA
spellingShingle Sheu Kadiri Rahamon
Sunday Peter Ogundeji
Samson Eshihokhale Olerimi
Kehinde Sola Akinlade
Rare occurrence of type 2 diabetes mellitus in patients with sickle cell anaemia: assessing the contribution of inflammation, insulin resistance and glucose buffering capacity of abnormal haemoglobin
Journal of Medical Science
Endocrinopathy
Haemoglobinopathy
Pharmacotherapy
Sickle cell anaemia
Type 2 diabetes mellitus
MicroRNA
title Rare occurrence of type 2 diabetes mellitus in patients with sickle cell anaemia: assessing the contribution of inflammation, insulin resistance and glucose buffering capacity of abnormal haemoglobin
title_full Rare occurrence of type 2 diabetes mellitus in patients with sickle cell anaemia: assessing the contribution of inflammation, insulin resistance and glucose buffering capacity of abnormal haemoglobin
title_fullStr Rare occurrence of type 2 diabetes mellitus in patients with sickle cell anaemia: assessing the contribution of inflammation, insulin resistance and glucose buffering capacity of abnormal haemoglobin
title_full_unstemmed Rare occurrence of type 2 diabetes mellitus in patients with sickle cell anaemia: assessing the contribution of inflammation, insulin resistance and glucose buffering capacity of abnormal haemoglobin
title_short Rare occurrence of type 2 diabetes mellitus in patients with sickle cell anaemia: assessing the contribution of inflammation, insulin resistance and glucose buffering capacity of abnormal haemoglobin
title_sort rare occurrence of type 2 diabetes mellitus in patients with sickle cell anaemia assessing the contribution of inflammation insulin resistance and glucose buffering capacity of abnormal haemoglobin
topic Endocrinopathy
Haemoglobinopathy
Pharmacotherapy
Sickle cell anaemia
Type 2 diabetes mellitus
MicroRNA
url https://jms.ump.edu.pl/index.php/JMS/article/view/604
work_keys_str_mv AT sheukadirirahamon rareoccurrenceoftype2diabetesmellitusinpatientswithsicklecellanaemiaassessingthecontributionofinflammationinsulinresistanceandglucosebufferingcapacityofabnormalhaemoglobin
AT sundaypeterogundeji rareoccurrenceoftype2diabetesmellitusinpatientswithsicklecellanaemiaassessingthecontributionofinflammationinsulinresistanceandglucosebufferingcapacityofabnormalhaemoglobin
AT samsoneshihokhaleolerimi rareoccurrenceoftype2diabetesmellitusinpatientswithsicklecellanaemiaassessingthecontributionofinflammationinsulinresistanceandglucosebufferingcapacityofabnormalhaemoglobin
AT kehindesolaakinlade rareoccurrenceoftype2diabetesmellitusinpatientswithsicklecellanaemiaassessingthecontributionofinflammationinsulinresistanceandglucosebufferingcapacityofabnormalhaemoglobin